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e tested whether the entire Golgi apparatus is
a dynamic structure in interphase mammalian
cells by assessing the response of 12 different
Golgi region proteins to an endoplasmic reticulum (ER) exit
block. The proteins chosen spanned the Golgi apparatus
and included both Golgi glycosyltransferases and putative
matrix proteins. Protein exit from ER was blocked either by
microinjection of a GTP-restricted Sar1p mutant protein in
the presence of a protein synthesis inhibitor, or by plasmid-
encoded expression of the same dominant negative Sar1p.
All Golgi region proteins examined lost juxtanuclear Golgi
apparatus–like distribution as scored by conventional and
confocal ﬂuorescence microscopy in response to an ER
exit block, albeit with a differential dependence on Sar1p
W
 
concentration. Redistribution of GalNAcT2 was more
 
sensitive to low Sar1p
 
dn
 
 concentrations than giantin or
GM130. Redistribution was most rapid for p27, COPI, and
p115. Giantin, GM130, and GalNAcT2 relocated with
approximately equal kinetics. Distinct ER accumulation
could be demonstrated for all integral membrane proteins.
ER-accumulated Golgi region proteins were functional.
Photobleaching experiments indicated that Golgi-to-ER
protein cycling occurred in the absence of any ER exit
 
block. We conclude that the entire Golgi apparatus is a
dynamic structure and suggest that most, if not all, Golgi
 
region–integral membrane proteins cycle through ER in
interphase cells.
 
Introduction
 
The Golgi apparatus occupies a central position within the
secretory pathway and is located as a compact juxtanuclear
structure in typical animal cells. It provides the organellar
framework in which proteins and lipids that originate in the
ER can undergo a series of posttranslational events including
glycosylation and sorting. These events are ordered cis, me-
dial to trans, entry to exit, across the stacked Golgi region
membranes. Unlike the ER, the Golgi apparatus itself has no
capacity to synthesize de novo either proteins or lipids. In a
fundamental sense, the Golgi apparatus must be derived
from the ER where the integral membrane components of
the Golgi apparatus are synthesized. Evolutionarily, the Golgi
apparatus may have originated as an outgrowth of the nu-
clear envelope (for review see Storrie et al., 2000). The ER
and nuclear envelope are continuous.
Several lines of evidence indicate that Golgi region pro-
teins cycle both within the Golgi apparatus itself and also
between the Golgi apparatus and ER, perhaps as a reflection
of the evolutionary relationship between the two organelles.
One mechanism is coatomer protein I (COPI)* coat pro-
tein–dependent transport. The COPI protein complex con-
sists of coatomer, a cytosolic complex, and arf-1, a small
GTPase active in the recruitment of coatomer to mem-
branes. COPI-coated vesicles bud from all levels of the Golgi
apparatus and COPI is required for intra-Golgi apparatus
transport in vivo (Pepperkok et al., 1993). Functional
COPI-derived vesicles or related transport intermediates can
be isolated or generated in vitro and have relatively high lev-
els of Golgi region–resident enzymes (Love et al., 1998;
Lanoix et al., 1999) and KDEL receptor (Sönnichsen et al.,
1996), consistent with these being recycling intermedi-
ates. Inhibition of COPI function through expression of mu-
tated arf-1 or microinjection of antibodies to COPI blocks
 
recycling of both the KDEL receptor and ERGIC53
from the Golgi apparatus to ER (Girod et al., 1999). The
KDEL receptor recognizes a COOH-terminal K(H)DEL
motif present in many lumenal, soluble ER proteins. The
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K(X)KXX motif present on many membrane proteins of the
ER binds to COPI in vitro, and mutations that abolish
binding result in the loss of reporter molecules to the cell
surface (Cosson and Letourneur, 1994). Likewise, the trans-
port from the Golgi apparatus to the ER of internalized pro-
teins such as cholera toxin or 
 
Pseudomonas
 
 exotoxin contain-
ing COOH-terminal KDEL or KDEL-like sequences is
blocked by microinjected antibodies to COPI (Majoul et al.,
1998; Jackson et al., 1999). COPI-dependent transport ap-
pears to mediate both intra-Golgi apparatus recycling of
Golgi glycosyltransferases and the transport of rapidly shut-
tling proteins such as the KDEL receptor and ERGIC53 be-
tween the Golgi apparatus and ER (for review see Storrie et
al., 2000).
Our work reveals the existence of a second COPI-inde-
pendent Golgi region transport mechanism which cycles
“resident” proteins from the Golgi apparatus to the ER
(Storrie et al., 1998; Yang and Storrie, 1998; Girod et al.,
1999; Storrie et al., 2000). The first inklings of a pathway
came from experiments in which Golgi apparatus scattering
in response to microtubule depolymerization was studied
with respect to the kinetics of individual Golgi region pro-
tein redistribution (Cole et al., 1996; Yang and Storrie,
1998). The observed kinetics were consistent with individ-
ual Golgi region proteins cycling to generate scattered Golgi
region stacks, perhaps de novo, at or about peripheral ER
exit sites. This apparent de novo formation of scattered
Golgi region stacks could be blocked by the introduction of
a GTP-restricted mutant Sar1p protein (Storrie et al., 1998).
Sar1p is required for COPII-dependent budding from the
ER. When ER exit is inhibited in interphase cells, Golgi re-
gion–resident glycosyltransferases such as GalNAcT2, GalT,
SialylT, and Mann II accumulate, albeit slowly, in the ER
(Storrie et al., 1998; Girod et al., 1999; Zaal et al., 1999;
Seemann et al., 2000; Todorow et al., 2000). This ER accu-
mulation is COPI-independent and rab6-dependent as indi-
cated by the effect of arf-1 and rab6 mutations and COPI
inhibitory antibodies (Girod et al., 1999). That Golgi appa-
ratus–resident proteins normally cycle to the ER in a COPI-
independent pathway was supported further by the finding
that the transport of Shiga-like toxin from the Golgi appara-
tus to the ER is similarly rab6-dependent and COPI-inde-
pendent (Girod et al., 1999). This finding is particularly im-
portant as toxin transport can be studied in wild-type cells in
the absence of any ER exit block. These results and the
COPI-dependent cycling of KDEL receptor and ERGIC53
to the ER suggest that the entire Golgi apparatus in inter-
phase cells is a metastable structure that is continuously be-
ing assembled and disassembled by a combination of COPI-
independent and -dependent mechanisms.
Protein cycling, though, may not be a general property of
the Golgi apparatus. The proposed cis Golgi matrix protein
GM130 (Golgi matrix polypeptide of 130 kD; Nakamura et
al., 1995) and other golgins interact strongly with each other
and also with the “tethering” protein p115 (Waters et al.,
1992) and the integral membrane protein giantin (Sönnich-
sen et al., 1998). The findings imply stability to the associa-
tion of such proteins with each other or membrane. Con-
ceivably, these proteins generate a cycling-insensitive Golgi
matrix and, in fact, experimental evidence indicating a cy-
cling-resistant GM130 complex has been presented (See-
 
mann et al., 2000). Seemann et al. (2000) find that the
integral membrane protein, giantin, and the peripheral
membrane proteins, GM130 and GRASP65, do not cycle in
response to microinjection of the ER exit block protein,
GTP-restricted Sar1p
 
dn
 
, at a stock concentration of 
 
 
 
0.7
mg/ml. Sar1p
 
dn
 
 is a dominant negative mutant of the small
GTPase required for the recruitment of COPII coat proteins
to the ER membrane (Aridor et al., 1995). Moreover, in
brefeldin A (BFA) washout experiments, these authors find
that the formation of a juxtanuclear Golgi “matrix” complex
is insensitive to microinjected Sar1p
 
dn
 
. BFA is a drug that
disperses many Golgi region proteins to the ER (for review
see Klausner et al., 1992). On the basis of these experiments,
Seemann et al. (2000) propose that a cycling-insensitive cis
Golgi matrix nucleates the assembly of the glycosyltrans-
ferase-containing Golgi apparatus stack.
In the present work, we compared, in HeLa cells, the ef-
fect of an ER exit block on the distribution of “resident”
Golgi region enzymes and putative matrix–interacting pro-
teins such as giantin, GM130, and p115. We emphasized
the plasmid-driven expression of the ER exit block protein,
Sar1p
 
dn
 
, as a tool because it provides a strong and constantly
produced source of the protein. The distributions of 12 dif-
ferent Golgi region proteins were characterized. All were
found to lose their juxtanuclear distribution in response to
the ER exit block, albeit with a differential dependence on
Sar1p
 
dn
 
 concentration. Perhaps, as expected for putative
Golgi matrix proteins, the redistribution of giantin and
GM130 required higher levels of Sar1p
 
dn
 
 than that of a
Golgi glycosyltransferase. Accumulation in the ER occurred
for all integral membrane proteins, even giantin. The kinet-
ics of redistribution were at least as fast for matrix proteins as
glycosyltransferases. Redistribution occurred in wild-type
cells expressing normal levels of Golgi region proteins and in
cells microinjected with the Sar1p
 
dn
 
 protein in the presence
of a protein synthesis inhibitor. The juxtanuclear distribu-
tion of organellar proteins was stable in the long-term pres-
ence of protein synthesis inhibitors, suggesting that mainte-
nance of a juxtanuclear Golgi apparatus requires protein and
presumably lipid cycling per se, rather than replacement of
degraded components. We conclude that the entire Golgi
apparatus may well cycle in interphase mammalian cells.
 
Results
 
Our goal was to provide evidence for or against the hypothe-
sis that the Golgi apparatus in interphase cells is a dynamic
structure, many, if not all, of whose proteins cycle between a
compact, juxtanuclear Golgi apparatus and peripheral or-
ganelles, most prominently the ER. To address this ques-
tion, we compared the effect of a GTP-restricted, Sar1p
 
dn
 
-
induced ER exit block on the distribution of proteins
normally located either in the cis Golgi apparatus/cis Golgi
network or the cisternal Golgi stack/TGN. In some experi-
ments the Sar1p
 
dn
 
 was directly microinjected into the cells.
This had the advantage that experiments could be done in
the presence of a protein synthesis inhibitor providing direct
evidence that any Golgi region protein redistribution was of
preexisting protein. In other experiments, the pSARA
 
dn
 
 plas-
mid–driven expression of Sar1p
 
dn
 
 was used as a tool because
it provides a strong and constantly produced source of the 
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protein, albeit with a time lag of 
 
 
 
30 min based on previous
experiments (Storrie et al., 1998). Protein distributions were
assessed using immunofluorescence or green fluorescent pro-
tein (GFP)-conjugated reporter molecules. As a functional
assay of Golgi region protein redistribution, the in situ gly-
cosylation state of a newly synthesized marker protein in the
ER of pSARA
 
dn
 
-expressing cells was characterized. Pho-
tobleaching was used to characterize the equilibration of
a GFP-conjugated Golgi glycosyltransferase between the
Golgi apparatus and ER pools as an additional independent
approach. With photobleaching, redistribution to the ER
can be investigated in the absence of any ER exit block.
 
Golgi glycosyltransferases and putative Golgi matrix 
proteins are dissimilar in the concentration of Sar1p
 
dn
 
 
required to induce relocation
 
Our first experiment was to compare the dependence of pu-
tative Golgi matrix and Golgi glycosyltransferase relocation
on Sar1p
 
dn
 
 concentration in the presence of the protein syn-
thesis inhibitor, cycloheximide (CHX). Example proteins
were chosen: giantin and GM130 as representative putative
Golgi matrix proteins and GalNAcT2 as a representative
Golgi glycosyltransferase. Giantin and GM130 interact to
form a complex (Sönnichsen et al., 1998) and may generate
a stable, cis-located Golgi matrix (Seemann et al., 2000).
GalNAcT2 is distributed across the entire Golgi stack (Rött-
ger et al., 1998) and has been shown previously to relocate
to the ER in response to a Sar1p
 
dn
 
-induced ER exit block
(Storrie et al., 1998, 2000; Girod et al., 1999). GalNAcT2
was expressed stably as a GFP fusion protein and either en-
dogenous giantin or GM130 were localized in the same cells
by immunofluorescence using a Cy3-conjugated second an-
tibody, and in the case of microinjected cells (asterisks) Cas-
cade blue dextran was the coinjection marker. All three
Golgi region proteins were located, in the absence of an ER
exit block, in a compact juxtanuclear distribution character-
istic of the Golgi apparatus in HeLa cells (Fig. 1, nonin-
jected cells). In cell populations microinjected with increas-
ing concentrations of Sar1p
 
dn
 
 in the presence of CHX, an
increasing proportion of the microinjected cells showed loss
of juxtanuclear Golgi apparatus fluorescence for the respec-
tive protein (Fig. 1, A–C, GalNAcT2 and giantin shown
qualitatively). At a concentration of 1.45 mg/ml Sar1p
 
dn
 
stock protein, 
 
 
 
60% of the microinjected cells stained for
giantin or GM130 exhibited extensive protein relocation 6 h
postinjection (Fig. 1 C). The redistribution of both giantin
and GM130 was indistinguishable in its Sar1p
 
dn
 
 concentra-
tion dependence. At the end of the 6 h incubation, both
had accumulated in somewhat granular staining structures
located throughout the cytoplasm. In striking contrast,
GalNAcT2 in the same microinjected cells redistributed to
an obvious ER-like distribution, as indicated by nuclear rim
staining and web-like distribution at a lower Sar1p
 
dn
 
 con-
centration. In 
 
 
 
80% of cells microinjected with 0.15 mg/
ml Sar1p
 
dn
 
, GalNAcT2 no longer had a juxtanuclear distri-
bution, but rather was distributed to the ER. We conclude
that both matrix and glycosyltransferases are distributionally
dynamic in response to an ER exit block, albeit with a differ-
ential sensitivity to Sar1p
 
dn
 
 dosage. As the amount of protein
microinjected per cell varied, the variable response of indi-
Figure 1. Concentration dependence of the Sar1p
dn induced redistri-
bution of GalNAcT2, giantin, and GM130. HeLa cells stably express-
ing GalNAcT2-GFP were microinjected with either various stock 
concentrations of Sar1p
dn protein (A–C) or pSARA
dn plasmid (D–F), 
incubated for 6 h at 37 C, and then fixed. In the case of cells microin-
jected with Sar1p
dn, the postinjection incubation was in the presence 
of CHX. Following fixation, cells were stained for either GM130 or 
giantin by immunofluorescence. In A and B, the Sar1p
dn stock concen-
tration was 0.15 mg/ml and the micrographs show cells double 
labeled for GalNAcT2-GFP and giantin. Asterisks over the cell nuclei 
indicate microinjected cells. Noninjected control cells are unmarked. 
Note that at this concentration GalNAcT2 had redistributed into an ER 
distribution in all four microinjected cells shown. Giantin, however, 
often displayed a more mixed distribution; all microinjected cells 
exhibited at least a partial diffuse cytoplasmic distribution for giantin 
with the left-hand cell exhibiting a full redistribution of giantin, and the 
other three injected cells also showing some concentrated juxtanu-
clear staining indicative of residual Golgi apparatus. In C, the 
incidence of microinjected cells displaying an overall pronounced 
juxtanuclear distribution for GalNAcT2, giantin, or GM130 was 
scored relative to the Sar1p
dn stock concentration as described 
previously (Girod et al., 1999). Two sets of data points are shown for 
GalNAcT2 because it was scored separately in giantin- and GM130-
stained cells. In D, the incidence of microinjected cells displaying an 
overall pronounced juxtanuclear distribution for GalNAcT2 or giantin 
was scored relative to the pSARA
dn stock concentration. In E and F, the 
pSARA
dn stock was either 8 ng or 200 ng/ l. At the low pSARA
dn 
concentration, a mixed pattern of giantin redistribution was common, 
whereas at the high concentration little incidence of juxtanuclear 
giantin staining was seen. The end giantin distribution was more gran-
ular than the continuous ER-like GalNAcT2 distribution. A coinjection 
marker was used to distinguish microinjected cells independently of 
phenotype. The average diameter of a HeLa nucleus is 10  m.
 
vidual microinjected cells was not surprising. The distribu-
tion of GalNAcT2-GFP was virtually identical whether ob-
served as the inherent fluorescence of the GFP conjugate or
after antibody staining with polyclonal antibodies directed 
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against full-length GFP (unpublished data), indicating that
the intrinsic fluorescence of the GFP was a bona fide indica-
tor of reporter protein distribution.
We next determined the dependence of giantin and
GalNAcT2 redistribution on the concentration of microin-
jected pSARA
 
dn
 
 plasmid. We had postulated that the plas-
mid-driven expression of Sar1p
 
dn
 
 should be a more effective
tool in producing relocation of Golgi region proteins. As
shown in Fig. 1, D–F, this proved to be the case, and at high
pSARA
 
dn
 
 concentrations both GalNAcT2 and giantin redis-
tributed to a similar extent. By fluorescence, the distribution
of GalNAcT2 and giantin were similar following a 6-h incu-
bation of cells microinjected with a high concentration of
pSARA
 
dn
 
 plasmid. Both appeared to have a distribution sug-
gestive of accumulation in the ER. To provide further evi-
dence of ER accumulation, giantin was colocalized relative
to GalNAcT2-GFP by confocal fluorescence microscopy.
GalNAcT2-GFP accumulates in the ER in correspondence
with protein disulfide isomerase in response to an ER exit
block (Storrie et al., 2000). As shown by confocal fluores-
cence microscopy in Fig. 2, giantin in pSARA
 
dn
 
-microin-
jected cells appeared to rim the cell nucleus in a somewhat
discontinuous pattern and to be present in general corre-
spondence to GalNAcT2-GFP at both the nuclear rim and
in the cytoplasm. There was extensive overlap between the
two in computer overlays. As further evidence and as a bio-
chemical assay of ER accumulation of the reference protein,
GalNAcT2, a Golgi apparatus–specific O-glycosylation en-
zyme, the in situ glycosylation state of an artificial substrate,
CD8, fused with the ER retention domain of glucuronyl-
transferase was characterized. This chimeric protein localizes
to the ER and is a potential substrate for in situ O-glycosyla-
tion by redistributed Golgi region enzymes. When Sar1p
 
dn
 
-
microinjected CD8 glucuronyltransferase cells were reacted
with rhodamine-conjugated Helix pomatia lectin, a lectin
specific for O-linked terminal 
 
 
 
-GalNAc, considerable ER-
specific staining was observed 6 h after pSARA
 
dn
 
 microinjec-
tion (Fig. 3, compare microinjected cells [asterisks] with
noninjected cells [arrowheads]), a result indicative of in situ
ER activity of Golgi apparatus–specific O-glycosylation en-
zymes. Note that Helix pomatia–specific staining was re-
stricted to a juxtanuclear, Golgi apparatus–like distribution
in the control, non-pSARA
 
dn
 
–injected cells.
 
Golgi glycosyltransferases and putative Golgi matrix 
proteins are similar in the kinetics of
Sar1p
 
dn
 
-induced relocation
 
Next, we examined the kinetics of relocation of a series of
Golgi matrix–localized proteins, including putative matrix
proteins and glycosyltransferases, in response to a high con-
centration of pSARA
 
dn
 
-induced ER exit block. The first ex-
ample protein was p27, a protein known to shuttle between
the cis Golgi apparatus and the ER (Füllekrug et al., 1999).
In the pSARA
 
dn
 
-injected cells (Fig. 4 A, asterisks), the distri-
bution of p27 was much more disperse even after only 2 h of
plasmid expression. Little to no juxtanuclear concentration
of p27 was apparent. Instead, low intensity, granular cyto-
Figure 2. Confocal fluorescence microscopy colocalizes giantin 
with GalNAcT2 in the ER of cells expressing pSARA
dn. HeLa cells 
stably transfected with GalNAcT2-GFP were microinjected with 
pSARA
dn. After a 6 h expression period, cells were fixed and stained 
for giantin using a Cy3-conjugated second antibody. A, giantin; B, 
GalNAcT2-GFP; C, overlay. As shown by the overlay, giantin and 
GalNAcT2 appeared to extensively colocalize to the nuclear 
envelope and elsewhere within the cytoplasm. Such localizations 
are characteristic of the ER. Asterisk (A) indicates microinjected cell.
Figure 3. Golgi apparatus–specific O-glycosylation occurs within 
the ER of Sar1p
dn-microinjected cells. Cells (asterisks) were microin-
jected with Sar1p
dn and at the end of 6 h, fixed and stained with 
rhodamine-conjugated Helix pomatia lectin. The target cell popula-
tion stably expresses an artificial ER-localized O-glycosylation 
substrate, CD8, fused with the ER retention domain of glucuronyl-
transferase. Helix pomatia lectin is a lectin specific for O-linked 
terminal  -GalNAc. In the microinjected cells, distinct staining of the 
nuclear envelope and into the cytoplasm was apparent. In the nonin-
jected cells (arrowheads), a distinct and fainter concentration of 
staining was apparent in the juxtanuclear Golgi complex–like region. 
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plasmic staining was observed. If anything, the redistribu-
tion of the cis Golgi matrix protein p27 was faster than that
of GalNAcT2-GFP in the same cells. As shown in Fig. 4 B,
considerable juxtanuclear GalNAcT2 remained after 2 h of
plasmid expression. However, cytoplasmic GalNAcT2 fluo-
rescence did increase considerably in the injected cells and
ER-like nuclear rim staining was apparent at higher magnifi-
cations. Cytoplasmic accumulation was due predominantly
to redistribution of components from juxtanuclear Golgi ap-
paratus. As shown explicitly in Fig. 4 C, p27 lost its juxtanu-
clear distribution in wild-type HeLa cells microinjected with
1.7 mg/ml Sar1p
 
dn
 
 and maintained in the presence of CHX
to inhibit protein synthesis. With favorable focus, p27 fluo-
rescence appeared to rim the nucleus (Fig. 4 C, inset, arrow-
 
head). Nuclear rim staining is characteristic of an ER accu-
mulation. This and similar experiments are also important as
they demonstrate redistribution in the absence of any Golgi
region protein overexpression, i.e., relocation is not a conse-
quence of spillover of overexpressed protein into an abnor-
mal pathway. To investigate the kinetic effect of an ER exit
block on a putative Golgi matrix–interacting protein local-
ized toward the cis Golgi complex, the pSARA
 
dn
 
 plasmid-
induced redistribution of giantin was compared with that of
GalNAcT2-GFP. As shown in Fig. 5, A–F, the loss of com-
pact, juxtanuclear distribution for giantin in pSARA
 
dn
 
-
expressing cells appeared similar to the slow redistribution
kinetics of GalNAcT2-GFP. A similar loss of juxtanuclear
giantin concentration was seen also in wild-type HeLa cells
microinjected with 1.7 mg/ml Sar1p
 
dn
 
 protein and main-
tained in the presence of CHX (Fig. 5 E, inset). As shown in
Fig. 5 F, inset, at 3.7-fold higher magnification, both giantin
and GalNAcT2 at 6 h pSARA
 
dn
 
 expression showed similar
rim staining of the nucleus, a characteristic trait of ER accu-
mulation.
To further assess whether there were kinetic differences
between Golgi region cisternal elements in response to an
Figure 4. Rapid redistribution of p27 in cells expressing pSARA
dn. 
HeLa cells stably expressing GalNAcT2-GFP were microinjected 
with pSARA
dn (A and B). At the end of a 2 h pSARA
dn expression 
period, cells were fixed and stained for p27 using a Cy3-conjugated 
second antibody. p27 (A) appeared to lose juxtanuclear Golgi 
apparatus–like localization faster than GalNAcT2 (B) in the same 
cells. Wild-type HeLa cells were microinjected with Sar1p
dn in the 
presence of CHX and incubated for 6 h postinjection (C). In these 
wild-type cells, p27 had completely lost juxtanuclear Golgi 
apparatus–like localization, and in favorable cells p27 staining 
appeared to localize to the nuclear envelope, e.g., arrowhead, inset. 
Asterisks indicate microinjected cells.
Figure 5. Similar redistribution kinetics for giantin and 
GalNAcT2-GFP in cells expressing pSARA
dn. HeLa cells stably 
transfected with GalNAcT2-GFP were microinjected with pSARA
dn 
in the absence of CHX. After 1 h (A and B), 2 h (C and D), or 6 h 
(E and F) expression period, cells were fixed and stained for giantin 
using a Cy3-conjugated second antibody. Giantin appeared to lose 
juxtanuclear Golgi apparatus–like localization with the same kinetics 
as GalNAcT2. As shown in 3.7  higher magnification inset to F, 
redistributed giantin and GalNAcT2-GFP similarly rimmed the 
nuclear envelope. As shown in the inset to E, giantin similarly
redistributed in wild-type HeLa cells microinjected with Sar1p
dn in 
the presence of CHX. Asterisks indicate microinjected cells. 
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ER exit block, the distributions of six different integral
membrane proteins of medial Golgi complex to TGN were
quantified in stably transfected HeLa cells microinjected
with 1.7 mg/ml Sar1p
 
dn
 
 in the presence of CHX. These cells
overexpress Golgi region proteins and therefore provide a
strong signal. Cells were scored semiquantitatively for onset
of ER distribution of marker protein (onset of nuclear rim
staining and web-like cytoplasmic staining) and predomi-
nantly juxtanuclear (i.e., Golgi complex) distribution. As
shown in Fig. 6, the two medial proteins, NAGT-I-myc and
MannII-VSV, were slower in initial ER appearance and loss
of juxtanuclear Golgi complex concentration than the trans-
to-TGN protein, GalT. However, a second trans-to-TGN
protein, ST-VSV, was also slow in initial ER appearance.
The redistribution of GalNAcT2-VSV, a protein that is ini-
tially distributed across the entire Golgi stack, and TGN38,
a classic marker of the TGN, appeared relatively fast. The
differences, although small, support at least in part the out-
come of experiments on the kinetics of Golgi apparatus re-
distribution in response to microtubule depolymerization
(Yang and Storrie, 1998), and also provide partial explana-
tions for the previous data. To test whether the cisternal
Golgi apparatus proteins redistributed in wild-type cells, the
distribution of endogenous TGN46, GalNAcT2, and GalT
was determined in nontransfected HeLa cells microinjected
 
with 1.7 mg/ml Sar1p
 
dn
 
 in the presence of CHX. A similar
loss of juxtanuclear Golgi complex staining was observed in
all cases 6 h postinjection (Fig. 6, B–D). However, little, if
any, distinct fluorescence signal could be detected about the
nuclear envelope as definitive evidence of ER localization.
We attribute this to insufficient signal to detect wild-type
levels of Golgi apparatus proteins upon their dilution into
the ER.
 
Golgi glycosyltransferases cycle in the absence of an 
ER exit block
 
The above experiments indicate eight different cis-to-TGN
integral Golgi apparatus membrane proteins plus GM130
and giantin cycle in response to an ER exit block. To pro-
vide direct evidence that such recycling is not an artifact of
the ER exit block, the equilibration of GalNAcT2-GFP be-
tween two pools, the Golgi apparatus and ER, was character-
ized by a photobleaching approach. As shown in Fig. 7 A,
inset, GalNAcT2-GFP fluorescence in cells stably expressing
high levels of the protein can be detected at high intensities
in association with the juxtanuclear Golgi apparatus and
at low intensities over the cytoplasm in association with
the ER. The ER fluorescence was not due to newly synthe-
sized GalNAcT2-GFP as it did not chase out of the ER with
incubation of the cells in the presence of CHX (unpub-
lished data; no ER exit block). To test whether the two
GalNAcT2-GFP pools were in equilibrium with one an-
other, GalNAcT2-GFP fluorescence over the cytoplasm was
photobleached in the presence of CHX and the same cell
was then imaged at 10 min intervals in the presence of drug.
As shown qualitatively in Fig. 7 A, inset, complete photore-
covery was seen. Quantitatively, recovery had a half time of
 
 
 
15 min, indicating that indeed GalNAcT2-GFP normally
is transported in a fairly rapid manner between the Golgi ap-
paratus and ER (Fig. 7 A). This half time was fourfold faster
than that for the loss of GalNAcT2-GFP–marked Golgi ma-
trix mass (average Golgi matrix pixel number per cells) in re-
sponse to an ER exit block (
 
t
 
1/2
 
 
 
 
 
 1 h; Fig. 7 B). The kinet-
ics for FRAP are similar to those reported by Zaal et al.
(1999). As an additional control that GalNAcT2-GFP had
accumulated in the ER, a continuous structure, in response
to the ER exit block, HeLa cells following a 6 h pSARA
 
dn
 
 ex-
pression period were photobleached over approximately
one-half the cell area and imaged at 1 min intervals. In these
cells, the Golgi apparatus had redistributed, presumably to
the ER. Extensive photorecovery was seen over a 4 min time
period over the bleached area (unpublished data), the ex-
pected result for an interconnected ER network.
 
GM130 relocates with similar kinetics to GalNAcT2
 
To test if an ER exit block results in the relocation of other
cis Golgi matrix proteins with similar kinetics to that of a
cisternal Golgi matrix enzyme, HeLa cells were micro-
injected with pSARA
 
dn
 
 and the distribution of endoge-
nous putative matrix or coat proteins observed relative to
GalNAcT2-GFP. As shown in Figs. 8–10, the concentrated
juxtanuclear distribution of each of the three peripheral pro-
teins decreased decidedly in a time-dependent manner.
COPI coat protein relocated rapidly and close to complete
loss of juxtanuclear fluorescence was observed after 1h (Fig.
Figure 6. Quantification and demonstration of the appearance of 
a series of Golgi apparatus cisternal and TGN proteins in the ER. In 
A, HeLa cells stably overexpressing a series of cisternal-to-TGN 
proteins were microinjected with Sar1p
dn in the presence of CHX 
and appearance in the ER quantified as described previously (Girod 
et al., 1999). In B–D, TGN46 (B), GalNAcT2 (C), and GalT (D) in 
wild-type HeLa cells microinjected with 1.7 mg/ml Sar1p
dn in the 
presence of CHX were localized 6 h post-injection. Asterisks 
indicate microinjected cells. 
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8). Much of this relocation may be to the cytosol. COPI ex-
ists as a membrane-associated coat and as soluble coato-
mer. p115 lost juxtanuclear localization at least as fast as
GalNAcT2-GFP (Fig. 9). GM130 relocated with roughly
the same kinetics as GalNAcT2-GFP (Fig. 10). To better
characterize the site of relocation of these peripheral proteins
in HeLa cells, the distribution of GM130 was determined in
GalNAcT2-VSV–tagged HeLa cells (Röttger et al., 1998)
microinjected with 150 ng/
 
 
 
l stock concentration pSARA
 
dn
 
,
incubated for 6 h, and then fixed with methanol. Methanol
fixation better preserves microtubules than formaldehyde
fixation and as such should give a better preservation of the
ER. The distribution of GM130 in the injected cells (Fig. 11
A, asterisks) was predominantly diffuse with some local con-
centrations. The diffuse labeling may well be cytosolic.
GalNAcT2 in the same cells displayed a distinctly ER-like
distribution (Fig. 11 B). We conclude that putative Golgi
matrix proteins including GM130 relocate, likely in part to
the cytosol, with roughly similar kinetics to GalNAcT2 in
response to a strong ER exit block.
As indicated by the normal distribution of Golgi region
proteins in non-Sar1p
 
dn
 
–microinjected cells in the presence
of CHX, the effect of an ER exit block upon Golgi matrix
protein distribution must be a consequence of a block of
protein cycling rather than the failure to replenish a short-
lived protein(s). This was further supported by the observa-
tion that the distribution of GalNAcT2-VSV was normal in
Sar1p
 
dn
 
-microinjected cells in the presence of 5 
 
 
 
g/ml eme-
Figure 7. Kinetics of GalNAcT2-GFP transfer between the Golgi 
apparatus and ER from photobleaching (A) or quantification of Golgi 
pixel mass (B). In A, fluorescence intensity over the ER region of 
individual cells was quantified before and after a photobleach in the 
presence of the protein synthesis inhibitor CHX. In this experiment, 
there is no ER exit block. The irregular line function of the ZEISS 
LSM510 microscope software was used to encircle the ER and the ER 
was then photobleached. Inset, qualitative evidence that the bleach is 
selective for the ER. The data are for three cells and the average inten-
sity and standard deviation are shown. About 35% of the ER-localized 
GFP was photobleached in each case. A partial photobleach rather 
than complete was chosen to minimize possible photodamage. Quan-
titatively, recovery of ER fluorescence was best fit by a single exponen-
tial function and had a half-time of 15 min. To image the less intense 
ER contribution, the Golgi apparatus was imaged to oversaturation. In 
B, loss of fluorescence from the Golgi apparatus following Sar1p
dn 
microinjection in the presence of CHX was analyzed based on mass 
action kinetics. Golgi area was scored by using the irregular line tool of 
the NIH Image program to enclose the juxtanuclear concentrated 
GalNAcT2-GFP pixels in  10 cells/time point. The total pixel number 
within the enclosed area was then quantified for 10 cells. Pixel number 
was used rather than summed fluorescence intensity because the Golgi 
apparatus had been imaged to oversaturation in the micrograph set in 
order to image the less intense ER contribution (see Fig. 6). The 
decrease in Golgi pixels with fluorescent signal was described well by 
a first-order rate constant (KGolgi-ER    0.5703 h
 1; R   0.99). The 
half-time for depletion is 1 h. Fluorescence appearance in the ER is 
described well by a first-order process with no depletion term, indicat-
ing that ER exit in the presence of Sar1p is not significant (unpublished 
data). The error bars in B indicate standard error of the mean.
Figure 8. COPI loses its juxtanuclear Golgi region localization 
faster than GalNAcT2-GFP in pSARA
dn-expressing cells. 
GalNAcT2-GFP HeLa cells were microinjected with pSARA
dn 
(asterisks) and fixed at 0 t and 1 and 3 h. Cells were stained for 
COPI using a Cy3 second antibody. 
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tine, a concentration sufficient to inhibit  99% of cytoplas-
mic protein synthesis in HeLa cells (Perlman and Penman,
1970; unpublished data).
Sar1p
dn inhibits the juxtanuclear accumulation of both 
Golgi glycosyltransferases and putative Golgi matrix 
proteins in BFA washout experiments
Others have provided evidence that after BFA treatment a
Golgi matrix consisting in part of giantin and GM130 pro-
vides a subsequent nucleus for Golgi apparatus reassembly in
a BFA washout experiment (Seemann et al., 2000). We have
tested this possibility in HeLa cells microinjected with both
moderately high (0.72 mg/ml) and high (2.85 mg/ml) stock
concentrations of Sar1p
dn. A 30-min exposure of HeLa cells
to BFA produced three different distributions for Golgi re-
gion proteins. GalNAcT2 was clearly redistributed to the
ER (Fig. 12 A). Giantin exhibited an ER-associated distribu-
tion, granular, but in clear correspondence to nuclear enve-
lope and web-like distribution of GalNAcT2 in the cyto-
plasm (Fig. 12 B). GM130 and p27 were distinctly different
in distribution and exhibited a scattered, granular distribu-
tion (Fig. 12 C, GM130 shown). To test whether these scat-
tered granular structures were nuclei for Golgi apparatus as-
sembly or BFA-arrested intermediates in protein cycling, we
probed the effect of Sar1p
dn on Golgi apparatus reassembly
following BFA washout. As shown in Fig. 12 H, little
GalNAcT2, p27, or GM130 accumulated juxtanuclearly
during a BFA washout in cells microinjected with 2.85 mg/
ml Sar1p
dn. Rather GalNAcT2 stayed predominantly ER in
distribution with some accumulation into scattered punctate
structures (Fig. 12 D). We attribute these to possible arrest
at ER exit sites. Endogenous p27 was distributed similarly
(Fig. 12 G) and GM130 on the whole exhibited a similar
distribution to GalNAcT2. However, in the case of endoge-
nous GM130, no distinct ER web–like or nuclear rim stain-
ing could be detected. This may reflect antibody strengths or
expression levels. In some cells, both GalNAcT2 and
GM130 could be seen, especially at low Sar1p
dn concentra-
tions, to exhibit a juxtanuclear concentration (Fig. 12, D
and F, insets). Giantin showed less tendency to accumulate
juxtanuclearly than GM130 (Fig. 12, E and H). We con-
clude at high Sar1p
dn levels that both Golgi complex glyco-
syltransferases and putative matrix components are sensitive
to an ER exit block.
Discussion
We assessed the response of 12 different Golgi matrix pro-
teins to an ER exit block (Table I) as a test of the hypothesis
Figure 9. p115 loses its juxtanuclear Golgi region localization in 
a similar manner to GalNAcT2-GFP in pSARA
dn-expressing cells. 
GalNAcT2-GFP HeLa cells were microinjected with pSARA
dn 
(asterisks) and fixed at 0 t and 1, 3, and 6 h. Cells were stained for 
p115 using a Cy3 second antibody. Only the 0 t and 3 h time points 
are shown.
Figure 10. GM130 loses its juxtanuclear Golgi region localization 
in a similar manner to GalNAcT2-GFP in pSARA
dn-expressing cells. 
GalNAcT2-GFP HeLa cells were microinjected with pSARA
dn (aster-
isks) and fixed at 2, 4, and 6 h. Cells were stained for GM130 using 
a Cy3 second antibody.
Figure 11. GM130 has a mixed diffuse and granular distribution 
in HeLa cells microinjected with pSARA
dn and fixed with methanol. 
HeLa cells stably expressing GalNAcT2-VSV were microinjected 
with 150 ng/ l stock concentration pSARA
dn, incubated for 6 h, and 
fixed with  20 C methanol to give better preservation of 
microtubules than with formaldehyde fixation. Microinjected cells 
were identified by the ER distribution of GalNAcT2 after antibody 
staining. GM130 has a diffuse to granular distribution in the 
microinjected cells. A, GM130; B, GalNAcT2. Asterisks indicate 
microinjected cells.Sensitivity of Golgi proteins to an ER exit block | Miles et al. 551
that the entire Golgi apparatus cycles in interphase mamma-
lian cells. The proteins chosen spanned the entire range of
cis-to-TGN and included examples of both putative Golgi
matrix proteins and Golgi matrix glycosyltransferases. In
general, distributions were scored in HeLa cells stably over-
expressing the protein of interest; this provided a stronger
signal upon dilution of the protein into the cytoplasm/ER.
Most protein distributions were assessed also in wild-type
HeLa cells. Protein exit from the ER was blocked either by
pSARA
dn-encoded expression of the Sar1p
dn protein or by
direct microinjection of the Sar1p
dn protein in the presence
of a protein synthesis inhibitor. Three key observations
emerged from these experiments. First, both putative Golgi
matrix proteins and Golgi glycosyltransferases lost their jux-
tanuclear localization in response to an ER exit block, albeit
with differential dependence on Sar1p
dn levels. The redistri-
bution of GalNAcT2 was more sensitive to low Sar1p
dn con-
centrations than that of giantin and GM130. Second, the re-
location of putative Golgi matrix proteins was at least as
rapid, if not more so, than that of Golgi glycosyltransferases,
no matter if cis or trans. In the case of “matrix,” some inte-
gral membrane proteins such as giantin redistributed in a
pattern very suggestive of the ER and others, peripheral
membrane proteins such as GM130, may relocate at least in
Figure 12. Sar1p
dn blocks the juxtanu-
clear accumulation of Golgi region 
proteins in a BFA washout protocol. 
HeLa cells stably expressing 
GalNAcT2-GFP were exposed to BFA 
for 30 min in the presence of CHX, 
fixed, and then stained. A, GalNAcT2-
GFP; B, giantin in same cells, double 
labeling; C, GM130. HeLa cells stably 
expressing GalNAcT2-GFP were 
microinjected with either 0.72 or 2.85 
mg/ml Sar1p
dn, incubated with BFA for 
30 min in the presence of CHX, and 
then incubated for an additional 2 h in 
the presence of CHX after BFA 
washout. D, GalNAcT2-GFP, 0.72 
mg/ml Sar1p
dn; E, giantin, 2.85 mg/ml 
Sar1p
dn; F, GM130, double labeling of 
same cells shown in D; G, p27, 2.85 
mg/ml Sar1p
dn; H, quantification of 
fluorescence distributions after BFA 
washout, scoring as described 
previously by Girod et al. (1999). 
Asterisks indicate microinjected cells.552 The Journal of Cell Biology | Volume 155, Number 4, 2001
part to the cytosol. For the coat protein, COPI, this was ap-
parently the case. Third, Golgi apparatus reassembly follow-
ing BFA washout was sensitive to an ER exit block irrespec-
tive of whether the distribution of a putative Golgi matrix
protein or a Golgi glycosyltransferase was assessed. Distinct
ER accumulation could be demonstrated for all integral
Golgi region membrane proteins, even giantin. ER-accumu-
lated Golgi region proteins were functional. Moreover, pho-
tobleaching experiments indicated that Golgi-to-ER protein
cycling occurred in the absence of an ER exit block. In sum,
these observations suggest that the entire Golgi apparatus is
a dynamic structure.
We deliberately choose to emphasize fluorescence assays
to assess phenotype because they permitted quantitative sur-
veys across target cell populations. In all cases, the pSARA
dn
plasmid or Sar1p
dn protein was introduced into the target
cell by microinjection. Through the use of a fluorescent
coinjection marker, we could score whether a cell was micro-
injected independent of phenotype. This permitted an ob-
jective assessment that pSARA
dn was more effective in redis-
tributing Golgi region proteins than microinjected Sar1p
dn.
Moreover, coinjection marker brightness provided an indi-
cation of how much Sar1p
dn had been transferred into the
individual cell. This was particularly important as a semi-
quantitative predictor of Sar1p
dn effect on the distribution of
putative matrix proteins. Electron microscope–based assays
(e.g., Seemann et al., 2000) are probably best applied to
pSARA
dn-microinjected cells where there is little variability
in phenotype from cell to cell with respect to the distribu-
tion of either a putative matrix protein or a Golgi glycosyl-
transferase. Our results are an extension of and consistent
with previous results (Storrie et al., 1998; Girod et al., 1999;
Zaal et al., 1999; Seemann et al., 2000; Todorow et al.,
2000) that individual Golgi glycosyltransferases cycle to the
ER. Clearly, as indicated by the greater granularity of redis-
tributed giantin than GalNAcT2, our data are insufficient to
prove that each protein is fully intermixed with other Golgi
proteins within the same element of ER. In our opinion, this
may well reflect the technical limitations of immunofluores-
cence; in our hands, two antibodies to the same ER protein
fail to give identical distributions in fixed cells (Storrie et al.,
1994). We note that even GalNAcT2 in the ER can show
concentrations of fluorescence (see Fig. 1 B; Girod et al.,
1999). As Sar1p redistributed GalNAcT2-GFP has a uni-
form ER distribution in living cells (unpublished data), we
conclude that preservation of structure during fixation and
antibody staining is a persistent problem.
Unlike Seemann et al. (2000), we find that putative Golgi
matrix components such as giantin, GM130, and p115 are
sensitive to a GTP-restricted ER exit block, albeit at a high
Sar1p
dn level. This is an important result and was observed
both for the disassembly of a juxtanuclear Golgi apparatus
and its reassembly following dispersal of many Golgi matrix
proteins to the ER through BFA treatment. Sensitivity was
essentially complete at high Sar1p
dn concentrations with the
pSARA
dn plasmid being the most effective vehicle for the in-
troduction of Sar1p
dn and producing subsequent matrix
protein redistribution. The kinetics of redistribution of
GM130, a peripheral membrane protein, at these pSARA
dn
concentrations was virtually identical to that of GalNAcT2.
GM130 redistribution was not to an obvious ER-like pat-
tern. Much of the distribution was diffuse, presumably cyto-
solic, and granular concentrations were observed. Granular-
ity in the distribution of giantin, an integral membrane
protein, appeared to overlap with ER. In agreement with
Seemann et al. (2000), we found redistribution of Golgi gly-
cosyltransferases to the ER was more sensitive to Sar1p
dn
than putative matrix proteins. Seemann et al. (2000) present
no concentration dependence data and no quantification of
phenotype. We find that at the same GTP-restricted Sar1p
dn
protein concentration used by Seemann et al. (2000) that
both giantin and GM130 had redistributed in  50% of the
microinjected cells. The images shown by Seemann et al.
(2000) are of single microinjected cells. Like Seemann et al.
(2000), we find that BFA disperses Golgi glycosyltrans-
ferases into the ER more effectively than putative Golgi ma-
trix components. We found that in BFA-treated cells that
giantin was dispersed into a somewhat discontinuous ER-
associated pattern and GM130 distributed into a granular
pattern much like that reported by Seemann et al. (2000).
Unlike Seemann et al. (2000), we found during Golgi appa-
ratus reassembly in BFA washout experiments, particularly
at high Sar1p
dn concentrations (2.85 mg/ml), that giantin,
GM130, and p27 distributed with GalNAcT2. The GM130
fluorescence signal was insufficient to say where dilute
GM130 might be located. Only concentrated GM130 could
Table I. Response of Golgi apparatus–associated proteins to an ER exit block
Protein Associated with putative matrix Initial localization End localization
a Kinetics of redistribution vs. GalNAcT2
p27 No Cis ER Faster
giantin Yes Cis ER Similar
NAGT-I No Medial/trans ER Slower
GalNAcT2 No Cis-trans ER Not applicable
Mann II No Medial/trans ER Slower
SialylT No Trans/TGN ER Slower
GalT No Trans/TGN ER Similar
TGN38 No TGN ER Similar
TGN46 No TGN ER Similar
COPI No Cis concentrated Cytoplasm Faster
p115 Yes Cis concentrated Cytoplasm Similar
GM130 Yes Cis concentrated Cytoplasm Similar
aIn the case of endogenous proteins, immunofluorescence staining can be readily assigned to the Golgi apparatus where the proteins are concentrated. How-
ever, in Sar1p
dn ER exit–blocked cells, the proteins are diluted as they redistribute and their end location within the cytoplasm may be difficult to assign.Sensitivity of Golgi proteins to an ER exit block | Miles et al. 553
be visualized and these concentrations corresponded to con-
centrations of GalNAcT2. GalNcT2, giantin and p27 were
found in predominantly ER-like distributions during BFA
washout in the presence of Sar1p
dn. This is particularly inter-
esting as p27 with BFA treatment displayed a granular dis-
tribution similar to GM130. These results suggest that in
BFA-treated cells p27 was cycling between a pre-Golgi appa-
ratus intermediate structure and the ER. This granular BFA
intermediate also could be an ER subdomain such as ER exit
sites. With BFA washout in the presence of Sar1p
dn, the cy-
cling protein was now blocked in a continuous ER distribu-
tion. In other words, the putative pre-Golgi structure is not
a stable intermediate.
Currently, two contrasting hypotheses of Golgi apparatus
assembly in mammalian cells contend with one another.
The one hypothesis, de novo Golgi apparatus assembly from
the ER, has been advanced on the basis of experiments in
which Golgi apparatus assembly is seen at scattered periph-
eral sites in nocodazole-treated cells in which the microtu-
bule network is depolymerized (e.g., Cole et al., 1996; Yang
and Storrie, 1998; Storrie et al., 1998) or concentrated GFP
chimeric proteins are used to study Golgi apparatus distribu-
tion in mitotic cells (Zaal et al., 1999). The other hypothe-
sis, nucleated assembly, postulates that a stable, vesicular-
associated Golgi matrix nucleates the downstream assembly
of the glycosyltransferase rich Golgi stack. This has been ad-
vanced on the basis of the experiments of Seemann et al.
(2000) reporting that a Golgi matrix is stable to an ER exit
block. Our experiments certainly cast doubt on this conten-
tion. The other experimental basis has been microsurgery ex-
periments in which cytoplasm is separated from juxtanuclear
Golgi complex and Golgi apparatus reassembly in the sepa-
rated cytoplasm is observed only when at least a few percent
of proteins, such as giantin, have been predispersed into the
cytoplasm before the microsurgery (Pelletier et al., 2000).
These experiments are important. They certainly indicate
that little in the way of Golgi region components are found
in the normal interphase ER. This conclusion is also sup-
ported by the morphometric distribution of GalNAcT2-
VSV in HeLa cells (Röttger et al., 1998; Storrie et al., 1998).
In our opinion, it is unlikely that there is a preformed Golgi
“matrix” at each site of Golgi apparatus assembly in the no-
codazole-treated cell. However, at present in the case of the
nocodazole-treated cell system, there are no data regarding
the order of “matrix” component assembly at the peripheral
sites versus Golgi glycosyltransferase assembly into a “new”
Golgi stack. Such data are needed. In our opinion, Golgi ap-
paratus assembly may well be an ordered process. Conceiv-
ably, the difference between these two hypotheses, de novo
versus nucleated assembly, may be kinetic in the sense that
the assembly of a cis Golgi region structure containing gian-
tin and GM130, for example, may well precede the assembly
of a glycosyltransferase-rich Golgi stack in all cases. If this is
true, then the question becomes what is the minimal initial
physical state, free or membrane associated, of GM130, for
example, as Golgi apparatus assembly begins. Additional ex-
perimentation will be necessary to define the dynamics of
GM130 and other “matrix” proteins in vivo in the absence
of any ER exit block and how they complex. The develop-
ment of a reversible Sar1p
dn block would greatly facilitate ex-
periments to address Golgi apparatus assembly questions in
vivo.
An individual transport step, the transport of Golgi glyco-
syltransferases from the Golgi apparatus to the ER, may be
faster than we previously thought on the basis of ER exit
block experiments alone (Storrie et al., 1998; Girod et al.,
1999). Consistent with previous data (Storrie et al., 1998;
Girod et al., 1999; Zaal et al., 1999; Seemann et al., 2000),
we found that the loss of Golgi complex mass (juxtanuclear
GalNAcT2–positive pixels) in response to an ER exit block
was relatively slow, with a half-time of  1 h. To our surprise,
we found that in photobleaching experiments in the absence
of an ER exit block that the half-time for ER transport (pho-
torecovery) for the same protein, GalNAcT2-GFP, was
0.25 h. Zaal et al. (1999) report similarly fast Golgi apparatus
to ER transport times in photobleaching recovery experi-
ments in the absence of an ER exit block. Although the Golgi
mass assay and the photobleaching Golgi apparatus to ER
fluorescence transfer assay do not measure the same parame-
ter, the photobleaching results suggest that the rate of Golgi
apparatus to ER transport step may well be more rapid than
we had thought previously. Zaal et al. (1999) show through
more extensive analysis a mean roundtrip Golgi glycosyl-
transferase cycling time of 84 min with a Golgi complex resi-
dence time of  57 min. We do not address overall cycling
times and Golgi complex residence times here. A mean cy-
cling time of 84 min is consistent with our observed slow loss
of Golgi apparatus mass, i.e., pixel number.
In conclusion, our data support the hypothesis that the
entire Golgi apparatus is a dynamic structure. The experi-
mental results cannot be explained on the basis of the meta-
bolic instability of a Golgi apparatus component. The juxta-
nuclear Golgi apparatus appears stable to almost complete
inhibition of protein synthesis for at least several hours. We
conclude that it is likely the entire Golgi apparatus cycles in
interphase mammalian cells with much of this cycling for in-
tegral membrane proteins being between the Golgi appara-
tus and ER. Peripheral Golgi apparatus–associated mem-
brane proteins such as COPI and GM130 also relocate and
are presumably in dynamic equilibrium with soluble cyto-
plasmic pools. Finally, we give caveat emptor caution to the
reader that, however much the major conclusion of a dy-
namic equilibrium Golgi apparatus is clear from our data,
the data are insufficient to give a full set of detailed conclu-
sions regarding the localization of proteins under all condi-
tions. We are at the limit of what fluorescence localization
can reveal. Other approaches will be necessary to fully re-
solve the nature of various granular staining structures.
Materials and methods
Cell culture
Wild-type HeLa cells were grown in DME supplemented with 10% fetal
bovine serum under standard tissue culture conditions. HeLa cells stably
expressing tagged Golgi apparatus proteins were maintained in the pres-
ence of 0.45 mg/ml of G-418 sulfate. HeLa cells localizing CD8 to the ER
through a fusion of the protein to the ER retention portion of glucuronyl-
transferase (clone 1:6:1) were a gift from Dr. Nilsson (European Molecular
Biology Laboratory, Heidelberg, Germany).
Microinjection of pSar1p
dn CMUIV (pSARA
dn [H79G] and 
Sar1p
dn [H79G])
Purified plasmids were microinjected into cell nuclei with minor modifica-554 The Journal of Cell Biology | Volume 155, Number 4, 2001
tions of previous procedures (Storrie et al., 1998). Typical plasmid concen-
trations were between 140 and 200 ng/ l, although in some experiments,
plasmid concentrations as low as 4 ng/ l were used. Sar1p
dn protein at an
injection concentration of 0.2–2.85 mg/ml was microinjected directly into
the cytoplasm of cells incubated in the presence of 100  g/ml CHX to in-
hibit protein synthesis during microinjection. Typical Sar1p
dn protein con-
centrations were 1.7–2.85 mg/ml. Protein-injected cells were subsequently
maintained in the presence of CHX during postmicroinjection culture.
Generally a coinjection marker (70 kD, aldehyde fixable, Cascade blue
dextran [Molecular Probes]) at a stock concentration of 3.33 mg/ml was
used as a coinjection marker.
BFA treatment and washout
HeLa cells were treated with BFA essentially as described by Seemann et
al. (2000). To disperse Golgi region proteins, cells cultured on coverslips
were incubated with 5  g/ml BFA for 30 min at 37 C in the presence of
CHX. To washout BFA, coverslips were transferred sequentially between a
series of four tissue culture dishes containing 2 ml each of room tempera-
ture CO2-independent microinjection media (GIBCO BRL) supplemented
with CHX and then transferred to warmed dishes containing 37 C com-
plete culture media supplemented with CHX. The subsequent incubation
period for Golgi apparatus reformation was 2 h. To investigate the effects
of microinjected Sar1p
dn on Golgi apparatus reformation, cells were mi-
croinjected with 0.72 or 2.85 mg/ml Sar1p
dn in the presence of CHX and
then incubated with BFA as described above.
Antibodies
Affinity-purified rabbit polyclonal antibodies directed against the VSV-G
epitope (CPYTDIEMNRLGK; Kreis, 1986) or p27 have been described previ-
ously (Röttger et al., 1998; Füllekrug et al., 1999). Rabbit polyclonal antibod-
ies recognizing human GalT polypeptide have been described by Watzele et
al. (1991). Rabbit polyclonal antibodies directed against GM130 were a gift
from Dr. Francis Barr (Max Planck Institute, Martinsried, Germany). Sheep
polyclonal antibodies directed against TGN46 were a gift from Dr. Vas Pon-
nambalam (University of Dundee, Dundee, UK). Rabbit polyclonal antibod-
ies directed against full-length GFP were purchased from Molecular Probes.
9E10 mouse monoclonal antibody (mAb) directed against a myc peptide
(Evan et al., 1985) was diluted from an ascites preparation for most purposes.
CM1A10 mAb directed against   -COPI and 4C4 mAb directed against
UDP-N-acetylgalactosylamine:polypeptide N-acetylgalactosaminyltransfer-
ase-2 (GalNAcT2) have been described previously (Palmer et al., 1993; Rött-
ger et al., 1998). mAb directed against giantin (Lindstedt and Hauri, 1993)
and mAb directed against rat TGN38 were gifts from Dr. Hans-Peter Hauri
(Biozentrum, University of Basel, Switzerland) and Dr. George Banting (Liv-
erpool, UK), respectively. Clone 35 mAb directed against GM130 and clone
46 mAb directed against p115 were purchased from Transduction Laborato-
ries. Cy3- or Cy2-conjugated donkey anti–rabbit, –mouse, or –sheep IgG an-
tibodies were obtained from Jackson ImmunoResearch Laboratories.
Conventional and live cell confocal fluorescence microscopy
Microinjected cells were fixed standardly with formaldehyde and perme-
abilized with Triton X-100 as described previously (Storrie et al., 1998). In
some experiments, cells were instead fixed with  20 C methanol for 4
min. With this fixation protocol, no further permeabilization treatment was
necessary for antibody labeling. Optimal visualization of the accumulation
of Golgi region proteins in the ER of microinjected cells frequently re-
quired overexposure of the fluorescence intensity present in juxtanuclear
Golgi apparatus of noninjected cells.
For live cell confocal microscopy, cells were viewed with a ZEISS LSM
510 microscope. Cells were maintained on the microscope stage at 37 C in
an FCS2 chamber (Bioptechs) or in a small aluminum slide chamber in com-
plete DME medium that had been preequilibrated in a CO2 incubator. The
small chamber was heated by conduction through the immersion oil from a
heated objective. This heating maintains the cells under immediate observa-
tion at 37 C. GFP was excited using the 488-nm line of the argon laser. In
FRAP experiments, ZEISS software was used to bleach either a rectangular
area or an irregular area corresponding to the ER by repeated scanning at
high laser intensity. Cells were observed at 1–10 min intervals following the
photobleach. Quantification was similar to that of Zaal et al. (1999).
Image processing and analysis of fluorescence intensity
All quantification of fluorescence intensity was done using gray scale im-
ages and the public domain software NIH Image v1.62 (developed at the
National Institutes of Health and available on the internet at http://
rsb.info.nih.gov/nih-image) as described previously (Storrie et al., 1998).
Protein distributions were scored in at least 30 cells per concentration or
time point as described previously (Girod et al., 1999).
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